Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Accelerating Implementation of Long-Acting Injectables
The ALAI UP Project will support the implementation and delivery of LAI ART at eight demonstration sites in EHE jurisdictions across the US providing care to underserved populations and communities of color.RWHAP Technical Assistance Provider updated on 07/09/2024
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
Aging with HIV Initiative
SPNS project evaluating interventions that seek to improve the well-being of RWHAP clients 50 and older. Project period: 2022-2025.RWHAP Technical Assistance Provider updated on 02/27/2024
-
Medicare Enrollment and Coverage for Ryan White HIV/AIDS Program (RWHAP) Clients
Best practices for providing Medicare enrollment support.Resource updated 03/11/2024
-
Trends, Patterns, and Factors Associated with HIV Coinfection Among Male Syphilis Cases, 2014-2019, Hawaii
By cross matching registries of HIV and other sexually transmitted infections, this study found 27.1% of male syphilis cases were coinfected with HIV and 31.8% of those coinfected were not virally suppressed. This suggests ongoing sexual risk behaviors and the potential for HIV transmission among male syphilis cases.
Resource (Conference Presentation) updated 09/14/2023
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Applying technological innovation: Harnessing an electronic patient portal to achieve a patient-centered approach to recertification
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
-
The Role of Peer Support Specialists within the Continuum of Services for Sexually Transmitted Infections
Utilization of a peer support specialist to increase routine bacterial sexually transmitted infection screening, testing, and treatment in an urban clinic and related patient care outcomes.
Resource (Conference Presentation) updated 09/14/2023
-
Promising Practices: The Impact of COVID-19 Related Policy Changes On Enrollment Capacity Within California's ADAP
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
-
Innovative approaches for risk-based assessment to increase STI screening for people with HIV
Screening protocols developed to identify more opportunities for testing at multiple sites and in asymptomatic individuals among persons at risk individuals with HIV to prevent and treat STIs.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Let's talk about the vicious cycle of annual 3 site STI screening for MSM
A NJ clinic has implemented multi-site STI screening for the clinic population and for higher risk groups. Gains made in implementation through prior quality initiatives were not sustained. The clinic worked collaboratively with a quality coach to identify how and why rectal swabs are overlooked, particularly when indicated.
Resource (Conference Presentation) updated 09/14/2023
-
Improving Routine Sexual Transmitted Infections (STI) Testing among People with HIV
Introduction. In Louisiana, the rates of sexually transmitted infections (STI) rank among the top ten. Approach. A sexual activity history was completed utilizing an audio computer-assisted self-interview tool. Results. Over 40% of the recommended STI screenings were extragenital testing. Discussion. A sexual activity history tool provides reliable recommendations for STI testing.
Resource (Conference Presentation) updated 09/14/2023
-
Listening Session on Policy Clarification Notice 16-02 Ryan White HIV/AIDS Program Services: Eligible Individuals and Allowable Uses of Funds
Listening Session on how Policy Clarification Notice 16-02 and how the HRSA HAB RWHAP service categories and allowable uses of funds can be refreshed to best reflect new and emerging needs, science, and service delivery models.
Resource (Conference Presentation) updated 09/14/2023
-
Community Co-Creation: Engaging Traditional and Nontraditional Partners in a National Viral Suppression Campaign
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
-
National HIV Curriculum 3rd Edition Launched
After extensive reviews and updates, the National HIV Curriculum 3rd Edition launched on September 1 to start a new 3-year CE accreditation period.News Article updated on 09/27/2023 -
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.Resource updated 04/12/2024
-
STI Implementation Plan Released
HHS has released an implementation plan on specific actions for entities to take in preventing and treating sexually transmitted infections (STI).News Article updated on 06/13/2023